Journal of Immunotherapy · 2018 · 21 citations · 19 references
Life SciencesImmunologyOncologyCancer ImmunologyCell TherapyTumor MicroenvironmentCancer ImmunotherapyImmune Cell InfiltrationImmune Cell TraffickingLeukocyte TraffickingLymphocyte TraffickingTumor-infiltrating LymphocytesCell InfiltrationIntra-arterial Cell AdministrationMurine ModelsT Cell Infiltration EnhancementT Cell Trafficking To TumorsTumor Growth RateTumor Immune Cell InfiltrationTumor Infiltration Assessment
Adoptive cell transfer therapy for cancer has existed for decades and is experiencing a resurgence in popularity that has been facilitated by improved methods of production, techniques for genetic modification, and host preconditioning. The trafficking of adoptively transferred lymphocytes and infiltration into the tumor microenvironment is sine qua non for successful tumor eradication; however, the paradox of extremely poor trafficking of lymphocytes into the tumor microenvironment raises the issue of how best to deliver these cells to optimize entry into tumor tissue. We examined the route of administration as a potential modifier of both trafficking and antitumor efficacy. Femoral artery cannulation and tail vein injection for the intra-arterial (IA) and IV delivery, respectively, were utilized in the B16-OVA/OT-I mouse model system. Both IV and IA infusions showed decreased tumor growth and prolonged survival. However, although significantly increased T-cell tumor infiltration was observed in IA mice, tumor growth and survival were not improved as compared with IV mice. These studies suggest that IA administration produces increased early lymphocyte trafficking, but a discernable survival benefit was not seen in the murine model examined.
19
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
Richard A. Morgan, Mark E. Dudley, John R. Wunderlich et al. · Science · 2006 · 2.6K citations · Full text
Medicine, Immunology, Oncology +14
Cassian Yee, John A. Thompson, D. Byrd et al. · Proceedings of the National Academy of Sciences · 2002 · 1.2K citations
Medicine, Immunology, Oncology +17